||Dr. Daniel R. Pascheles
Vice President, Head Global Competitive Intelligence
Merck & Co.
Dr. Daniel R. Pascheles is Vice President, Global Competitive Intelligence, and is based in Whitehouse Station NJ, at the Global HQ of Merck & Co., Inc.
His responsibilities include providing intelligence regarding business, research and development activities of competitors, as well as participating in, and
contribution to the strategy development process, the target identification for licensing and M&A activities.
Pascheles joined Merck & Co., Inc. early 2005 from Aventis Inc. where he was Vice President and head of Corporate Competitive Intelligence. He has
worked for Aventis and its predecessor company (Hoechst Marion Roussel, Marion Merrell Dow) for 14 years in various positions and locations.
Pascheles studied Pharmacy at the Swiss Federal Institute of Technology in Zurich, Switzerland. He received his Ph.D. in Pharmaceutical Technology from
the same university. He has done additional study at the University of Kansas in Lawrence, Kansas.
Pascheles is Past-President and current Board member of the Pharmaceutical Business Intelligence & Research Group (PBIRG). He is also member of the
Society of Competitive Intelligence Professionals (SCIP) and the Licensing Executive Society (LES).
Senior Director, Worldwide Competitive Intelligence
Sue Ward is currently Senior Director of Worldwide Competitive Intelligence within Pfizer’s Corporate Strategic Planning group. Previously within Pfizer,
Sue led the competitive intelligence team within Information & Knowledge Management. Prior to joining Pfizer, Sue worked in the UK as Associate
Director of Competitive Analysis for SmithKline Beecham (SB) (now GSK). Other positions held by Sue within SB included managing a Clinical Information
group and the Product Literature Information Service. Sue holds a BSc (Hons) in Biology from University College London and an MSc in Information
Science from The City University, London .